NovoCure Ltd — Director's Dealing 2020

Feb 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2020-02-24

Reporting Person: Shah Pritesh (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-24	Ordinary Shares	M	12999	$88.26	Acquired	80720	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-24	Restricted Stock Units	$0.0	M	12999	Disposed		Ordinary Shares (12999.0)	Direct

Footnotes

F1: Fully vested as of the date hereof.